Evolving Trends in Adult Heart Transplant With the 2018 Heart Allocation Policy Change

Arman Kilic1, Michael A Mathier2, Gavin W Hickey2

  • 1Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

JAMA Cardiology
|October 28, 2020
PubMed

Insights

The US heart transplant policy change in 2018 improved waitlist outcomes but decreased post-transplant survival. Continued evaluation of the new heart allocation policy is crucial.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Health Policy

Background:

  • The US heart allocation policy was revised on October 18, 2018.
  • The impact of this policy change on recipient and donor selection and outcomes requires thorough investigation.

Purpose of the Study:

  • To assess changes in patient characteristics, waitlist outcomes, and post-transplant outcomes following the recent heart transplant allocation policy revision.
  • To evaluate the association between the policy change and heart transplant outcomes.

Main Methods:

  • A cohort study reviewed 15,631 adult heart transplants in the US from a national registry.
  • Patients were stratified into pre-policy change (Oct 1, 2015 - Oct 1, 2018) and post-policy change (Oct 18, 2018 onwards) groups.
  • Competing risk regression and multivariable Cox proportional hazards regression were used to analyze outcomes.

Main Results:

  • Post-policy change, waitlisted patients had a reduced likelihood of mortality or deterioration (SHR, 0.60) and increased likelihood of transplant (SHR, 1.38).
  • However, post-transplant survival decreased after the policy change (1-year survival: 92.1% vs 87.5%, P<.001), persisting after risk adjustment (HR, 1.29).
  • Changes included increased use of temporary mechanical circulatory support and decreased use of durable left ventricular assist devices for bridging.

Conclusions:

  • The 2018 US heart allocation policy revision led to improved waitlist outcomes but a decline in post-transplant survival.
  • These trends have persisted through 1-year follow-up, highlighting the need for ongoing reevaluation of the policy.
  • The findings underscore the complex trade-offs associated with organ allocation policy changes.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
187
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
169
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
115
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
753